| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
Director |
Common Stock |
41.6K |
$84.5K |
$2.03 |
18 Jun 2024 |
Direct |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
Director |
Stock Option (right to buy) |
65K |
|
|
04 Jun 2025 |
Direct |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
Direct |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
MDV ENF VII (A), L.P. |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
MDV ENF VII (B), L.P. |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
MDV VII Leaders' Fund, L.P. |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
MDV VII, L.P. |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP |
| Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Stock Option (Right to Buy) |
0 |
|
|
24 Nov 2021 |
Direct |